Which of the following prokinetic drugs has been implicated in causing serious ventricular arrhythmias, particularly in patients concurrently receiving erythromycin or ketoconazole?
## Core Concept
The question tests knowledge of the side effects of prokinetic agents, specifically their potential to cause serious cardiac arrhythmias when used concomitantly with certain other medications. Prokinetic drugs enhance gastrointestinal motility by various mechanisms, including the modulation of neurotransmitter release.
## Why the Correct Answer is Right
The correct answer, , is associated with a risk of serious ventricular arrhythmias, particularly when co-administered with drugs that inhibit the cytochrome P450 enzyme system, such as erythromycin or ketoconazole. This is because is metabolized by the cytochrome P450 system, and inhibition of this system can lead to elevated levels of the drug, prolonging the QT interval and increasing the risk of arrhythmias.
## Why Each Wrong Option is Incorrect
* **Option A:** is not commonly associated with this specific side effect profile related to QT interval prolongation and serious ventricular arrhythmias when used with erythromycin or ketoconazole.
* **Option B:** does not have a significant association with the described cardiac side effects, particularly in the context of interactions with erythromycin or ketoconazole.
* **Option D:** is not known for causing serious ventricular arrhythmias through a mechanism involving QT interval prolongation, especially with concurrent use of the mentioned drugs.
## Clinical Pearl / High-Yield Fact
A key point to remember is that certain prokinetic agents can have serious cardiac side effects, particularly when co-administered with inhibitors of the cytochrome P450 system. This interaction can lead to QT prolongation and increase the risk of life-threatening arrhythmias.
## Correct Answer Line
**Correct Answer: C. **